EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Multilayer pH ‐Responsive Hydrogels Upcycled From Carrageenan‐Based Capsule Residues for Colon‐Targeted Delivery of 5‐Aminosalicylic Acid

Hoai‐Khang Tran, Tien‐Ngo Van, Hong Ha Nguyen, Thi Thuy Hang Hoang, Ngoc Hai Vu, Colin J. Barrow, Hoang Chinh Nguyen

Journal of Biomedical Materials Research Part A · 2026-11 · 114 (11)

DOI: 10.1002/jbm.a.70196 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Softgel capsule manufacturing generates substantial carrageenan‐containing byproducts that are typically discarded, despite their intrinsic gel‐forming and polyelectrolyte‐complexing capability. This study reports a sustainable strategy for upcycling carrageenan‐based capsule residues (CCR) into multilayer pH‐responsive hydrogel beads for colon‐targeted delivery of 5‐aminosalicylic acid (5‐ASA). CCR hydrogel cores were prepared by K + ‐mediated ionotropic gelation, followed by sequential coating with chitosan and alginate to form double‐layer (CCR/Cs) and triple‐layer (CCR/Cs/Alg) beads. Morphological and structural analyses suggested successful layer formation and interfacial interactions. The layer‐by‐layer assembly substantially enhanced network stability, increasing the gel fraction from 52% for CCR to 78% for CCR/Cs/Alg beads. In simulated gastric fluid (pH 1.2), CCR and CCR/Cs released 56.93% and 60.41% of 5‐ASA, respectively, whereas CCR/Cs/Alg limited release to 28.09%, demonstrating superior acid resistance. Under simulated intestinal (pH 6.8) and colonic (pH 7.4) conditions, CCR/Cs/Alg beads exhibited a controlled, stepwise drug release, reaching 45.88% at 5 h and 70.16% at 8 h. Release kinetics were best fitted by the Korsmeyer–Peppas model ( R 2 = 0.9928, n = 0.7480), suggesting contributions from both drug diffusion and polymer‐network relaxation to the observed release behavior. These findings demonstrate that carrageenan‐based capsule residues can serve as a primary structural feedstock for fabricating multilayer pH‐responsive hydrogels with gastric protection and controlled drug release. This work also provides a value‐added pathway for converting pharmaceutical manufacturing residues into functional biomaterials for targeted drug delivery.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →